Table 1.

De novo hepatitis B occurred in recipients with different serological status and without receiving prophylaxis

HBV serology	References	DNH/total (%)
Anti-HBs (−), anti-HBc (−)	[3–5, 7, 15–27]	86/132 (65.2)
Anti-HBs (+), anti-HBc (−)	[5, 7, 16–18, 20, 21, 24, 25, 27–31]	9/45 (20)
Anti-HBs (−), anti-HBc (+)	[5, 7, 16, 19, 21, 25, 27, 32]	8/41 (19.5)
Anti-HBs (+), anti-HBc (+)	[7, 16, 19, 21, 22, 26, 27, 29, 31, 32]	2/47 (4.3)

HBV hepatitis B, anti-HBs antibody against hepatitis B surface antigen, anti-HBc antibody against hepatitis B core antigen, DNH de novo hepatitis B